We’re successfully offering a new minimally invasive, single-incision procedure to patients who need surgery to address both mitral valve disease and hypertrophic obstructive cardiomyopathy.
Concurrent HOCM and Barlow’s valve can prove vexing, as standard therapy for one is counterproductive to the other. We share a case study with lessons for overcoming this clinical challenge.
A large retrospective study suggests that factoring myectomy and atrial fibrillation into risk scores for sudden cardiac death significantly reclassifies risk in patients with hypertrophic cardiomyopathy.
A large retrospective study suggests that left ventricular global longitudinal strain measurement can help identify at-risk patients with obstructive HCM who may benefit from earlier myectomy.